Accolade To Buy 2nd.MD To Boost Telehealth Options
PYMNTS
JANUARY 15, 2021
Healthcare technology company Accolade is buying telemedicine startup 2nd.MD The sale is likely to go forward for $460 million, according to CNBC, and Accolade will purchase 2nd.MD Half of the transaction will go through in cash, while the other half will be in Accolade shares. parent company Innovation Specialists.
Let's personalize your content